TABLE 2.
Serotype coverage of pneumococcal vaccines among Japanese pediatric patients with AOM, based on age and penicillin susceptibility
| Vaccine type (established formula) | No. (%) of isolates from indicated age group
|
|||||
|---|---|---|---|---|---|---|
| ≤2 yr
|
≥3 yr
|
All
|
||||
| PRSP (n = 34) | Total (n = 107) | PRSP (n = 12) | Total (n = 68) | PRSP (n = 46) | Total (n = 175) | |
| 7-Valent (4, 6B, 9V, 14, 18C, 19F, 23F) | 30 (88.2) | 73 (68.2) | 10 (83.3) | 33 (48.5) | 40 (87.0) | 106 (60.6) |
| 10-Valent (1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F) | 30 (88.2) | 74 (69.2) | 10 (83.3) | 34 (50.0) | 40 (87.0) | 108 (61.7) |
| 13-Valent (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F) | 33 (97.1) | 92 (86.0) | 11 (91.7) | 53 (77.9) | 44 (95.7) | 145 (82.9) |
| 23-Valent (1, 3, 4, 5, 6B, 7F, 8, 9V, 9N, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 22F, 23F, 33F) | 30 (88.2) | 78 (72.9) | 10 (83.3) | 51 (75.0) | 40 (87.0) | 129 (73.7) |